Celcuity Inc. (CELC) financial statements (2023 and earlier)

Company profile

Business Address 16305 36TH AVENUE N
MINNEAPOLIS, MN 55446
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments84,28611,63818,73524,89824,197
Cash and cash equivalents84,28611,63818,73515,9452,640
Short-term investments   8,95321,557
Restricted cash and investments    50
Receivables299190190  
Prepaid expense723317275270210
Deferred costs22 2929 
Deposits current assets2222222228
Total current assets:85,35212,16719,25025,21824,484
Noncurrent Assets
Finance lease, right-of-use asset (49) 
Operating lease, right-of-use asset242231197
Property, plant and equipment312559833814280
Long-term investments and receivables    7,205
Long-term investments    7,205
Other undisclosed noncurrent assets 49   
Total noncurrent assets:5547901,0308147,485
TOTAL ASSETS:85,90612,95720,28126,03231,970
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,310992727657578
Accounts payable1,50721714312072
Accrued liabilities803775584537506
Debt61931846 
Other undisclosed current liabilities190    
Total current liabilities:2,5061,185911662578
Noncurrent Liabilities
Long-term debt and lease obligation14,690697220 
Long-term debt, excluding current maturities14,626    
Finance lease, liability2814
Capital lease obligations20 
Operating lease, liability626158
Other undisclosed noncurrent liabilities(62)    
Total noncurrent liabilities:14,690697220 
Total liabilities:17,1961,254983682578
Stockholders' equity
Stockholders' equity attributable to parent68,71011,70219,29825,35031,391
Common stock1510101010
Additional paid in capital124,62238,01436,13534,82733,389
Accumulated deficit(55,927)(26,322)(16,847)(9,488)(2,007)
Total stockholders' equity:68,71011,70219,29825,35031,391
TOTAL LIABILITIES AND EQUITY:85,90612,95720,28126,03231,970

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Operating expenses(28,356)(9,556)(7,805)(7,933)(5,953)
Operating loss:(28,356)(9,556)(7,805)(7,933)(5,953)
Nonoperating income (expense)(1,249)82446452(299)
Investment income, nonoperating 82446449153
Other nonoperating expense(1,249)    
Interest and debt expense(1,262)(0)(0)(0)(452)
Loss from continuing operations before equity method investments, income taxes:(30,868)(9,474)(7,360)(7,481)(6,703)
Other undisclosed income from continuing operations before income taxes1,262000452
Net loss available to common stockholders, diluted:(29,605)(9,474)(7,359)(7,481)(6,252)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(29,605)(9,474)(7,359)(7,481)(6,252)
Comprehensive loss, net of tax, attributable to parent:(29,605)(9,474)(7,359)(7,481)(6,252)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: